A chromosomal aneuploidy is a condition where the number of chromosomes in a cell is incorrect, because of either an extra chromosome or a missing chromosome. The discovery of cell-free nucleic acid ...
Interpace Diagnostics, a provider of molecular diagnostic tests and pathology services for evaluating risk of cancer, has received approval from an unspecified major national managed care organization ...
PARSIPPANY, NJ, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG), a fully integrated commercial company that provides clinically relevant ...
PARSIPPANY, NJ, June 04, 2024 (GLOBE NEWSWIRE) -- Interpace Diagnostics ®, a subsidiary of Interpace Biosciences ® (OTCQX: IDXG), is proud to announce that new data demonstrating the application of ...
Novitas Solutions, the Medicare Administrative Carrier for Interpace Diagnostics Group, has created a new code for Interpace's PancraGen test to improve provider reimbursement. Below are three things ...
PARSIPPANY, N.J., Aug. 13, 2015/ PRNewswire/-- PDI, Inc. subsidiary Interpace Diagnostics announced today that both the ThyGenX™ Thyroid Oncogene Panel and ThyraMIR™ Thyroid miRNA Classifier, its ...
Parsippany-based Interpace Diagnostics, a subsidiary of Interpace Biosciences, announced Monday it entered a contract with Blue Cross Blue Shield of Massachusetts—with more than three million members ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback